This report contains market size and forecasts of Atherosclerosis Drugs in Global, including the following market information:
Global Atherosclerosis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Atherosclerosis Drugs market was valued at 39510 million in 2021 and is projected to reach US$ 43370 million by 2028, at a CAGR of 1.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atherosclerosis Drugs include GlaxoSmithKline, Sanofi, F. Hoffmann-L a Roche, Bayer, Novartis, Merck, Janssen Pharmaceutical, Amgen and Pfizer. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Atherosclerosis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atherosclerosis Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Atherosclerosis Drugs Market Segment Percentages, by Type, 2021 (%)
- Corticosteroids
- PDE4 Inhibitors
- Biologics
- Skin Barrier Emollients
- CNI Immunosuppressants
- Others
Global Atherosclerosis Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Atherosclerosis Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinic
- Retail Pharmacies
- Other
Global Atherosclerosis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Atherosclerosis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atherosclerosis Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Atherosclerosis Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GlaxoSmithKline
- Sanofi
- F. Hoffmann-L a Roche
- Bayer
- Novartis
- Merck
- Janssen Pharmaceutical
- Amgen
- Pfizer
Atherosclerosis Drugs Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Atherosclerosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Atherosclerosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Atherosclerosis Drugs Overall Market Size
2.1 Global Atherosclerosis Drugs Market Size: 2021 VS 2028
2.2 Global Atherosclerosis Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Atherosclerosis Drugs Players in Global Market
3.2 Top Global Atherosclerosis Drugs Companies Ranked by Revenue
3.3 Global Atherosclerosis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Atherosclerosis Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Atherosclerosis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Atherosclerosis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Atherosclerosis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Atherosclerosis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Atherosclerosis Drugs Market Size Markets, 2021 & 2028
4.1.2 Corticosteroids
4.1.3 PDE4 Inhibitors
4.1.4 Biologics
4.1.5 Skin Barrier Emollients
4.1.6 CNI Immunosuppressants
4.1.7 Others
4.2 By Type - Global Atherosclerosis Drugs Revenue & Forecasts
4.2.1 By Type - Global Atherosclerosis Drugs Revenue, 2017-2022
4.2.2 By Type - Global Atherosclerosis Drugs Revenue, 2023-2028
4.2.3 By Type - Global Atherosclerosis Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Atherosclerosis Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Retail Pharmacies
5.1.5 Other
5.2 By Application - Global Atherosclerosis Drugs Revenue & Forecasts
5.2.1 By Application - Global Atherosclerosis Drugs Revenue, 2017-2022
5.2.2 By Application - Global Atherosclerosis Drugs Revenue, 2023-2028
5.2.3 By Application - Global Atherosclerosis Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Atherosclerosis Drugs Market Size, 2021 & 2028
6.2 By Region - Global Atherosclerosis Drugs Revenue & Forecasts
6.2.1 By Region - Global Atherosclerosis Drugs Revenue, 2017-2022
6.2.2 By Region - Global Atherosclerosis Drugs Revenue, 2023-2028
6.2.3 By Region - Global Atherosclerosis Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Atherosclerosis Drugs Revenue, 2017-2028
6.3.2 US Atherosclerosis Drugs Market Size, 2017-2028
6.3.3 Canada Atherosclerosis Drugs Market Size, 2017-2028
6.3.4 Mexico Atherosclerosis Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Atherosclerosis Drugs Revenue, 2017-2028
6.4.2 Germany Atherosclerosis Drugs Market Size, 2017-2028
6.4.3 France Atherosclerosis Drugs Market Size, 2017-2028
6.4.4 U.K. Atherosclerosis Drugs Market Size, 2017-2028
6.4.5 Italy Atherosclerosis Drugs Market Size, 2017-2028
6.4.6 Russia Atherosclerosis Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Atherosclerosis Drugs Market Size, 2017-2028
6.4.8 Benelux Atherosclerosis Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Atherosclerosis Drugs Revenue, 2017-2028
6.5.2 China Atherosclerosis Drugs Market Size, 2017-2028
6.5.3 Japan Atherosclerosis Drugs Market Size, 2017-2028
6.5.4 South Korea Atherosclerosis Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Atherosclerosis Drugs Market Size, 2017-2028
6.5.6 India Atherosclerosis Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Atherosclerosis Drugs Revenue, 2017-2028
6.6.2 Brazil Atherosclerosis Drugs Market Size, 2017-2028
6.6.3 Argentina Atherosclerosis Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Atherosclerosis Drugs Revenue, 2017-2028
6.7.2 Turkey Atherosclerosis Drugs Market Size, 2017-2028
6.7.3 Israel Atherosclerosis Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Atherosclerosis Drugs Market Size, 2017-2028
6.7.5 UAE Atherosclerosis Drugs Market Size, 2017-2028
7 Players Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Atherosclerosis Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Atherosclerosis Drugs Revenue in Global Market (2017-2022)
7.1.5 GlaxoSmithKline Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Atherosclerosis Drugs Major Product Offerings
7.2.4 Sanofi Atherosclerosis Drugs Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 F. Hoffmann-L a Roche
7.3.1 F. Hoffmann-L a Roche Corporate Summary
7.3.2 F. Hoffmann-L a Roche Business Overview
7.3.3 F. Hoffmann-L a Roche Atherosclerosis Drugs Major Product Offerings
7.3.4 F. Hoffmann-L a Roche Atherosclerosis Drugs Revenue in Global Market (2017-2022)
7.3.5 F. Hoffmann-L a Roche Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Atherosclerosis Drugs Major Product Offerings
7.4.4 Bayer Atherosclerosis Drugs Revenue in Global Market (2017-2022)
7.4.5 Bayer Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Atherosclerosis Drugs Major Product Offerings
7.5.4 Novartis Atherosclerosis Drugs Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Atherosclerosis Drugs Major Product Offerings
7.6.4 Merck Atherosclerosis Drugs Revenue in Global Market (2017-2022)
7.6.5 Merck Key News
7.7 Janssen Pharmaceutical
7.7.1 Janssen Pharmaceutical Corporate Summary
7.7.2 Janssen Pharmaceutical Business Overview
7.7.3 Janssen Pharmaceutical Atherosclerosis Drugs Major Product Offerings
7.7.4 Janssen Pharmaceutical Atherosclerosis Drugs Revenue in Global Market (2017-2022)
7.7.5 Janssen Pharmaceutical Key News
7.8 Amgen
7.8.1 Amgen Corporate Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Atherosclerosis Drugs Major Product Offerings
7.8.4 Amgen Atherosclerosis Drugs Revenue in Global Market (2017-2022)
7.8.5 Amgen Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Atherosclerosis Drugs Major Product Offerings
7.9.4 Pfizer Atherosclerosis Drugs Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Atherosclerosis Drugs Market Opportunities & Trends in Global Market
Table 2. Atherosclerosis Drugs Market Drivers in Global Market
Table 3. Atherosclerosis Drugs Market Restraints in Global Market
Table 4. Key Players of Atherosclerosis Drugs in Global Market
Table 5. Top Atherosclerosis Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Atherosclerosis Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Atherosclerosis Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Atherosclerosis Drugs Product Type
Table 9. List of Global Tier 1 Atherosclerosis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Atherosclerosis Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Atherosclerosis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Atherosclerosis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Atherosclerosis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Atherosclerosis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Atherosclerosis Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Atherosclerosis Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Atherosclerosis Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Atherosclerosis Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Atherosclerosis Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Atherosclerosis Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Atherosclerosis Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Atherosclerosis Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Atherosclerosis Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Atherosclerosis Drugs Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Atherosclerosis Drugs Product Offerings
Table 32. GlaxoSmithKline Atherosclerosis Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Atherosclerosis Drugs Product Offerings
Table 35. Sanofi Atherosclerosis Drugs Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-L a Roche Corporate Summary
Table 37. F. Hoffmann-L a Roche Atherosclerosis Drugs Product Offerings
Table 38. F. Hoffmann-L a Roche Atherosclerosis Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Bayer Corporate Summary
Table 40. Bayer Atherosclerosis Drugs Product Offerings
Table 41. Bayer Atherosclerosis Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Atherosclerosis Drugs Product Offerings
Table 44. Novartis Atherosclerosis Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Atherosclerosis Drugs Product Offerings
Table 47. Merck Atherosclerosis Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Janssen Pharmaceutical Corporate Summary
Table 49. Janssen Pharmaceutical Atherosclerosis Drugs Product Offerings
Table 50. Janssen Pharmaceutical Atherosclerosis Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Amgen Corporate Summary
Table 52. Amgen Atherosclerosis Drugs Product Offerings
Table 53. Amgen Atherosclerosis Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Atherosclerosis Drugs Product Offerings
Table 56. Pfizer Atherosclerosis Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Atherosclerosis Drugs Segment by Type in 2021
Figure 2. Atherosclerosis Drugs Segment by Application in 2021
Figure 3. Global Atherosclerosis Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Atherosclerosis Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Atherosclerosis Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Atherosclerosis Drugs Revenue in 2021
Figure 8. By Type - Global Atherosclerosis Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Atherosclerosis Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Atherosclerosis Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Atherosclerosis Drugs Revenue Market Share, 2017-2028
Figure 12. US Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Atherosclerosis Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Atherosclerosis Drugs Revenue Market Share, 2017-2028
Figure 24. China Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Atherosclerosis Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Atherosclerosis Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Atherosclerosis Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Atherosclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Atherosclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-L a Roche Atherosclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer Atherosclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Atherosclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Atherosclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Janssen Pharmaceutical Atherosclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amgen Atherosclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Atherosclerosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Global Digoxin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 75
According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period.
The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......
Global Heart Failure Drugs Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 116
According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......
Global Atorvastatin Calcium Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 138
According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......
Global Rosuvastatin Calcium Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 139
According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......
Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 133
According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period.
Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......
Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 132
According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period.
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......
Cilostazol - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 118
The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......
Rosuvastatin - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 110
Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well.
The global Rosuvastatin market size is expected......
Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 19-Dec-2023 Price: US 3380 Onwards Pages: 123
Market Overview of Global Congestive Heart Failure Drugs market:
According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
